EY5-31766-84213
3 vaccinations
1 coded response
4 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 007 / PR
- Registered
- 2021-07-12
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Registered dependents
XVY-14894-83625
Child or adolescent in my care · Male · 2022-01-17
Timeline
-
2021-05-12
Dose 1 — Pfizer-BioNTech
-
2021-06-02
Dose 2 — Pfizer-BioNTech
-
2021-07-12
Registered in v-safe
- 2021-07-12
- 2021-07-16
- 2021-09-03
-
2021-12-06
Dose 3 — Pfizer-BioNTech
-
2022-03-07
Survey response — 3 months, dose 3MedDRA: Headache, Pain — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitMedDRA releases: 2024-11
-
2022-03-07
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-12 | Pfizer-BioNTech | No |
| 2 | 2021-06-02 | Pfizer-BioNTech | No |
| 3 | 2021-12-06 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release